$224M
$144,000
0.0% of portfolio
6,059
Q3 2024
Reduced 3.95%
$5.61B
$10.6 Million
0.0% of portfolio
92,661
Q3 2024
Added 166.41%
$1.22B
$1.74 Million
0.0% of portfolio
121,982
Q3 2024
Added 2.29%
$9.25B
$54.4 Million
0.0% of portfolio
280,407
Q3 2024
Added 105.67%
$993M
$2.32 Million
0.0% of portfolio
77,083
Q3 2024
Reduced 38.13%
$177M
$87,000
0.0% of portfolio
3,430
Q3 2024
Added 14.87%
$407M
$439,000
0.0% of portfolio
9,373
Q3 2024
Reduced 13.74%
$121M
$297,000
0.0% of portfolio
34,812
Q3 2024
Reduced 3.53%
-
$0
0.0% of portfolio
-
Q3 2024
Added 15.79%
$1.87B
$2.57 Million
0.0% of portfolio
115,694
Q3 2024
Reduced 4.01%
$1.09B
$8.89 Million
0.0% of portfolio
460,185
Q3 2024
Added 74.43%
$2.63B
$9.47 Million
0.0% of portfolio
125,499
Q3 2024
Reduced 56.57%
-
$0
0.0% of portfolio
-
Q3 2024
New
$230M
$318,000
0.0% of portfolio
85,182
Q3 2024
Added 5.23%
$2.05B
$24 Million
0.0% of portfolio
1,788,898
Q3 2024
Added 3.59%
-
$0
0.0% of portfolio
-
Q3 2024
Added 72.19%
$182M
$134,000
0.0% of portfolio
10,986
Q3 2024
Added 20.26%
$124M
$1,000
0.0% of portfolio
119
Q3 2024
Added 80.3%
$615M
$242,000
0.0% of portfolio
20,374
Q3 2024
Added 9.43%
$615M
$455,000
0.0% of portfolio
48,752
Q3 2024
Added 21.51%
$3.88B
$57 Million
0.0% of portfolio
2,174,457
Q3 2024
Added 9.75%
$180M
$1.31 Million
0.0% of portfolio
243,001
Q3 2024
Added 1,467.04%
Perspective Therapeutics Inc
-
$0
0.0% of portfolio
-
Q3 2024
Added 157.7%
$768M
$3.26 Million
0.0% of portfolio
967,152
Q3 2024
Reduced 31.94%
$908M
$10.2 Million
0.0% of portfolio
330,197
Q3 2024
Added 65.95%
$98.8M
$292,000
0.0% of portfolio
79,388
Q3 2024
Added 38.09%
-
$2.66 Million
0.0% of portfolio
202,662
Q3 2024
Reduced 98.82%
Petros Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q3 2024
Added 33.33%
-
$0
0.0% of portfolio
-
Q3 2024
New
$0
$1.8 Million
0.0% of portfolio
141,236
Q3 2024
Added 3.71%
$0
$5.5 Million
0.0% of portfolio
394,229
Q3 2024
Added 5.39%
$35.5M
$0
0.0% of portfolio
117
Q3 2024
Reduced 23.03%
$755M
$0
0.0% of portfolio
15
Q3 2024
Reduced 99.75%
$351M
$1.88 Million
0.0% of portfolio
103,779
Q3 2024
Added 5.86%
-
$0
0.0% of portfolio
-
Q3 2024
New
$480M
$705,000
0.0% of portfolio
31,360
Q3 2024
Reduced 24.94%
$4.64B
$12.6 Million
0.0% of portfolio
334,635
Q3 2024
Added 1.49%
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 2.98%
Phio Pharmaceuticals Corp
-
$0
0.0% of portfolio
-
Q3 2024
New
$6.29M
$0
0.0% of portfolio
165
Q3 2024
Added 32.0%
$1.49B
$4.45 Million
0.0% of portfolio
179,626
Q3 2024
Added 78.39%
$1.07B
$10.3 Million
0.0% of portfolio
452,731
Q3 2024
Added 4.48%
-
$0
0.0% of portfolio
-
Q3 2024
Added 38.24%
$136M
$105,000
0.0% of portfolio
31,171
Q2 2024
Reduced 5.84%
$222M
$909,000
0.0% of portfolio
101,807
Q3 2024
Added 37.21%
$879M
$5.39 Million
0.0% of portfolio
756,545
Q3 2024
Added 0.03%
Pieris Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q2 2024
New
$0
$4.15 Million
0.0% of portfolio
249,676
Q3 2024
Added 19.52%
$0
$435,000
0.0% of portfolio
43,680
Q3 2024
Added 21.74%
$0
$148,000
0.0% of portfolio
23,581
Q3 2024
Added 20.43%